TNYA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -1.68. Updated 2026-07-23.
Tenaya Therapeutics (TNYA) Research Hub
Tenaya Therapeutics (TNYA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.64 USD (-3.18%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.68, market cap 0.13B. This hub links to the full technical, earnings and options research available for TNYA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.64 USD (-3.18%) |
| 52-week range | 0.64 USD – 0.947 USD |
| Trend regime | Range |
| 14-day RSI | 27.1 (Oversold) |
| Trailing P/E | -1.68 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
Available research for TNYA
Covered Call on TNYA: how it works, illustrative setup around the real 0.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TNYA: how it works, illustrative setup around the real 0.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TNYA: how it works, illustrative setup around the real 0.64 USD price, max profit/loss, breakeven and when to use it. Educational.
TNYA technical analysis: range, last 0.64 USD, RSI 27.1, 52w range 0.64 USD–0.947 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TNYA in?
Tenaya Therapeutics (TNYA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TNYA in an uptrend or downtrend?
As of 2026-09-11, TNYA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TNYA's trailing P/E ratio?
TNYA's trailing P/E is -1.68, with a market cap of 0.13B. See the earnings research page for full valuation detail.